Method development and validation of taurolidine and heparin in tablet dosage form by using rp-hplc.
Keywords:
Taurolidine and Heparin, RP-HPLC, Validation, Robustness, ICH GuidelinesAbstract
A new, simple and accurate, precise RP-HPLC method was developed for simultaneous determination of Taurolidine and Heparin in bulk and in combined pharmaceutical dosage form. The separation of Taurolidine and Heparin was achieved within 8 minutes on an Agilent Zorbax (C18) (150mm x 4.6mm, 5µm) column using Methanol: Acetate Buffer pH-3.8 (24:76v/v) as the mobile phase. Detection was carried out using wavelength at 262nm. The method showed adequate sensitivity concerning linearity, accuracy and precision over the range 100-500μg/ml and 30-70μg/ml for Taurolidine and Heparin, respectively. Careful validation proved advantages of high sensitivity, accuracy, precision, selectivity, robust and suitability for quality control laboratories. The developed method was robust as the %RSD was within the range and without effecting system suitability parameters. The proposed method is suitable for simultaneous determination of Taurolidine and Heparin in bulk and pharmaceutical dosage form.
Published
Issue
Section
Copyright (c) 2024 Futuristic Publications

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.